ArticleJournal of experimental & clinical cancer research : CR2017

The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.

Yassar M Hashim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.